117 related articles for article (PubMed ID: 9870897)
1. The pharmacokinetics of the kininogens.
Schmaier AH; Wahl R; Fisher SJ; Brenner D
Thromb Res; 1998 Dec; 92(6):293-7. PubMed ID: 9870897
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the presence of a kininogen-like species in a case of total deficiency of low and high molecular weight kininogens.
Veloso D
Braz J Med Biol Res; 1998 Jul; 31(7):901-10. PubMed ID: 9698753
[TBL] [Abstract][Full Text] [Related]
3. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation.
Meloni FJ; Schmaier AH
J Biol Chem; 1991 Apr; 266(11):6786-94. PubMed ID: 2016293
[TBL] [Abstract][Full Text] [Related]
4. Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosis.
Cugno M; Scott CF; Salerno F; Lorenzano E; Müller-Esterl W; Agostoni A; Colman RW
Thromb Haemost; 1999 Nov; 82(5):1428-32. PubMed ID: 10595632
[TBL] [Abstract][Full Text] [Related]
5. The kinin released from high molecular weight-kininogen is responsible for inflammatory exudation in rats: detection of kinin-free-kininogen in the exudate by immunoblot analysis.
Fujie H; Hayashi I; Oh-ishi S
Life Sci; 1993; 53(22):1691-701. PubMed ID: 8231650
[TBL] [Abstract][Full Text] [Related]
6. A mechanism for hereditary angioedema caused by a methionine-379-to-lysine substitution in kininogens.
Dickeson SK; Kumar S; Sun MF; Litvak M; He TZ; Phillips DR; Roberts ET; Feener EP; Law RHP; Gailani D
Blood; 2024 Feb; 143(7):641-650. PubMed ID: 37992228
[TBL] [Abstract][Full Text] [Related]
7. Bradykinin regulates the expression of kininogen binding sites on endothelial cells.
Zini JM; Schmaier AH; Cines DB
Blood; 1993 Jun; 81(11):2936-46. PubMed ID: 8388750
[TBL] [Abstract][Full Text] [Related]
8. Domain 3 of kininogens contains a cell-binding site and a site that modifies thrombin activation of platelets.
Jiang YP; Muller-Esterl W; Schmaier AH
J Biol Chem; 1992 Feb; 267(6):3712-7. PubMed ID: 1740422
[TBL] [Abstract][Full Text] [Related]
9. High-molecular-mass and low-molecular-mass kininogens block plasmin-induced platelet aggregation by forming a complex with kringle 5 of plasminogen/plasmin.
Selim TE; Ghoneim HR; Uknis AB; Colman RW; DeLa Cadena RA
Eur J Biochem; 1997 Dec; 250(2):532-8. PubMed ID: 9428707
[TBL] [Abstract][Full Text] [Related]
10. Insights on monoclonal antibodies to kininogens' heavy chain which influence kininogens' binding to platelets.
Jiang Y; Nawarawong W; Meloni FJ; Schmaier AH
Thromb Haemost; 1992 Aug; 68(2):143-8. PubMed ID: 1412158
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin release from high molecular weight kininogen and increase in plasma kallikrein-like activity following sensory stimulation by food in the rat.
Rothschild AM; Gomes EL; Fortunato IC
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):483-8. PubMed ID: 9826071
[TBL] [Abstract][Full Text] [Related]
12. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage.
Meloni FJ; Gustafson EJ; Schmaier AH
Blood; 1992 Mar; 79(5):1233-44. PubMed ID: 1536948
[TBL] [Abstract][Full Text] [Related]
13. Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens.
Sugi T; McIntyre JA
J Autoimmun; 2001 Nov; 17(3):207-14. PubMed ID: 11712858
[TBL] [Abstract][Full Text] [Related]
14. Whale high-molecular-weight and low-molecular-weight kininogens.
Semba U; Shibuya Y; Okabe H; Hayashi I; Yamamoto T
Thromb Res; 2000 Mar; 97(6):481-90. PubMed ID: 10704658
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of inhibition of platelet calpain II by human kininogens.
Bradford HN; Schmaier AH; Colman RW
Biochem J; 1990 Aug; 270(1):83-90. PubMed ID: 2396995
[TBL] [Abstract][Full Text] [Related]
16. Rapid direct determination of low and high molecular weight kininogen in human plasma by Particle Concentration Fluorescence Immunoassay (PCFIA).
Scott CF; Shull B; Müller-Esterl W; Colman RW
Thromb Haemost; 1997 Jan; 77(1):109-18. PubMed ID: 9031459
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of kininogen deficiency in brown Norway Katholiek rats.
Oh-ishi S; Hayashi I; Hosiko S; Makabe O
Braz J Med Biol Res; 1994 Aug; 27(8):1803-15. PubMed ID: 7749370
[TBL] [Abstract][Full Text] [Related]
18. Primary structures of guinea pig high- and low-molecular-weight kininogens.
Semba U; Umeda Y; Shibuya Y; Okabe H; Tanase S; Yamamoto T
Int Immunopharmacol; 2004 Oct; 4(10-11):1391-400. PubMed ID: 15313436
[TBL] [Abstract][Full Text] [Related]
19. Expression of thrombospondin 1 on the surface of activated platelets mediates their interaction with the heavy chains of human kininogens through Lys 244-Pro 254.
DeLa Cadena RA; Kunapuli SP; Walz DA; Colman RW
Thromb Haemost; 1998 Jan; 79(1):186-94. PubMed ID: 9459346
[TBL] [Abstract][Full Text] [Related]
20. Kallikrein-kininogen system activation and bradykinin (B2) receptors in indomethacin induced enterocolitis in genetically susceptible Lewis rats.
Stadnicki A; Sartor RB; Janardham R; Stadnicka I; Adam AA; Blais C; Colman RW
Gut; 1998 Sep; 43(3):365-74. PubMed ID: 9863482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
